MiR-15a-16 represses Cripto and inhibits NSCLC cell progression

Molecular and Cellular Biochemistry

Volumn 391, Issue 1-2, 2014, Pages 11-19

  Chen, Feng ^a   Hou, Shi Ke ^a   Fan, Hao Jun ^a   Liu, Ying Fu ^a  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Apoptosis; Cripto; Invasion; miR 15a 16; NSCLC

Indexed keywords

MICRORNA 15A; MICRORNA 16; 3' UNTRANSLATED REGION; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN15 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN; PROTEIN BINDING; SIGNAL PEPTIDE; TDGF1 PROTEIN, HUMAN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE CONTROL; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LUCIFERASE ASSAY; LUNG CANCER CELL LINE; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE CRIPTO; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEIN BINDING;

EID: 84900810454     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-1981-y     Document Type: Article

References (27)

1. Bach PB (2011) Inconsistencies in findings from the early lung cancer action project studies of lung cancer screening. J Natl Cancer Inst 103(13):1002-1006
2. Van't Westeinde SC, van Klaveren RJ (2011) Screening and early detection of lung cancer. Cancer J 17(1):3-10
3. Brivanlou AH et al (2003) Stem cells. Setting standards for human embryonic stem cells. Science 300(5621):913-916
4. Ciardiello F et al (1994) Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene 9(1):291-298 (Pubitemid 24020961)
5. Xing PX et al (2004) Cripto: a novel target for antibody-based cancer immunotherapy. Cancer Res 64(11):4018-4023 (Pubitemid 38697318)
6. Normanno N et al (2004) Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells. J Cell Physiol 198(1):31-39 (Pubitemid 38120963)
7. Bianco C et al (2006) Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res 12(17):5158-5164 (Pubitemid 44453344)
8. Bianco C et al (2013) Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. J Cell Physiol 228(6):1174-1188
9. Soria-Valles C et al (2013) The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene. doi:10.1038/onc.2013.267
10. Kang HW et al (2012) miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett 586(6):897-904
11. Ma L (2010) Role of miR-10b in breast cancer metastasis. Breast Cancer Res 12(5):210
12. Takakura S et al (2008) Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci 99(6):1147-1154 (Pubitemid 351676626)
13. Wu H, Zhu S, Mo YY (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 19(4):439-448
14. Selcuklu SD et al (2012) MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 287(35):29516-29528
15. Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17(2):193-199
16. Liu C et al (2012) Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 72(13):3393-3404
17. Bonci D et al (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14(11):1271-1277
18. Bhattacharya R et al (2009) MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69(23):9090-9095
19. Luo Q et al (2013) MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Int J Oncol 43(4):1212-1218
20. Dai L et al (2012) Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo. Cell Biol Int 36(8):765-770
21. Bandi N et al (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69(13):5553-5559
22. Bandi N, Vassella E (2011) miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer 10:55
23. Jusufovic E et al (2012) let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-small-cell lung cancer. PLoS ONE 7(9):e45577
24. Yang M et al (2013) High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 49(3):604-615
25. Zhang JG et al (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411(11-12):846-852
26. Yuxia M, Zhennan T, Wei Z (2012) Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol 138(12):2045-2050
27. Aqeilan RI, Calin GA, Croce CM (2010) miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17(2):215-220